05/16/2018
by Kenny Dolgin, Data Insights, Guidepoint Abiomed, Inc. (NYSE: ABMD) is a leader in the percutaneous heart pump device market, having launched its first Impella device in 2008 and have since released four iterations with varying flow rates. From May…
